Antonin Holy and Erik De Clercq became co-inventors of a key class of antiviral drugs a.o. Tenofovir to combat the HIV virus

Products resulting from the Holý-De Clercq collaboration and commercialized by Gilead (photo courtesy Gilead Sciences, Inc.)

Medical Faculty in Leuven, Belgium September 13, 2017

1/7

Erik De Clercq M.D. Ph.D.

Tenofovir at the crossroad of the therapy and profylaxis of HIV and HBV (2020)